Reclassifying dropouts from antipsychotic trials due to study-reported adverse events: a systematic review and individual-participant-data meta-analyses

Citation:

Furukawa Y, Siafis S, Schneider-Thoma J, et al. Eur Neuropsychopharmacol. 2026 May 15;111:112874. Epub ahead of print. PMID: 42139983.